Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (KCT0012813) titled 'A Human study to evaluate the effect on the skin health and safety of Limosilactobacillus fermentum MG5368' on Oct. 21.
Study Type: Interventional Study
Study Design:
Primary Purpose : Other(skin health improvement))), Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
Primary Sponsor: Global Medical Research Center
Condition:
Not Applicable
Intervention:
Dietary Supplement : At Visit 1 (Week -2), volunteers who have voluntarily signed the informed consent form for the human study undergo an eligibility assessment based on inclusion and exclusion c...